🇺🇸 FDA
Patent

US 9714232

Substituted piperazine compounds and methods of use thereof

granted A61KA61K31/496A61K31/497

Quick answer

US patent 9714232 (Substituted piperazine compounds and methods of use thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE LAKE PHARMA CO., LTD.
Grant date
Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/496, A61K31/497, A61K31/513, A61K31/5377